Cargando…
Integrating systematic pharmacology-based strategy and experimental validation to explore mechanism of Tripterygium glycoside on cholangiocyte-related liver injury
OBJECTIVE: Tripterygium glycoside (TG) is widely used in clinical practice for its multiple bioactivities including anti-inflammatory and immunosuppressive effects. However, emerging studies have frequently reported TG-induced adverse reactions to multiple organs, especially liver. Here, this study...
Autores principales: | Li, Yajing, Li, Sen, Xue, Xiaoyong, Wang, Ting, Li, Xiaojiaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669401/ https://www.ncbi.nlm.nih.gov/pubmed/36405068 http://dx.doi.org/10.1016/j.chmed.2022.02.006 |
Ejemplares similares
-
Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
por: Lin, Na, et al.
Publicado: (2021) -
Glycyrrhizic acid glycosides reduces extensive tripterygium glycosides-induced lipid deposition in hepatocytes
por: Yang, Yifei, et al.
Publicado: (2023) -
Wells Syndrome Successfully Treated with Tripterygium Glycosides
por: Lu, Jiejie, et al.
Publicado: (2021) -
Effects of tripterygium glycosides on restenosis following endovascular treatment
por: HAN, BING, et al.
Publicado: (2016) -
Proteomic Study on the Reproductive Toxicity of Tripterygium Glycosides in Rats
por: Dai, Yanlin, et al.
Publicado: (2022)